Kymera Therapeutics, Inc. - Common Stock, $0.0001 par value per share (KYMR)

Q: What does CUSIP 501575104 represent in this 13F holders report?

CUSIP 501575104 is the security identifier for KYMR - Kymera Therapeutics, Inc. - Common Stock, $0.0001 par value per share used to aggregate holder disclosures.

Q: How many institutions held KYMR - Kymera Therapeutics, Inc. - Common Stock, $0.0001 par value per share in Q3 2022?

119 institutional investors reported KYMR - Kymera Therapeutics, Inc. - Common Stock, $0.0001 par value per share for Q3 2022. Use the holders table for investor-level position and value details.

CUSIP: 501575104

Q3 2022 13F Holders as of 30 Sep 2022

Security type / class: Equity / Common Stock, $0.0001 par value per share
Total 13F shares: 52,859,306
Total 13F value: $1,150,805,258
Share change: +1,319,884
Put/Call ratio: 22%
SEC-reported price per share: $21.77
Number of holders: 119
Value change: +$29,150,428
Number of buys: 73
Number of sells: 42
Shares outstanding: 83,129,381

Security key

501575104

Report period

Q3 2022

Institutions

119

Top holders

KYMR full security history Ownership snapshot Full 13F holder table Newer quarter: Q4 2022 Previous quarter: Q2 2022 Kymera Therapeutics, Inc. SEC filings Kymera Therapeutics, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 501575104

Newer quarter: Q4 2022 Previous quarter: Q2 2022

Recent filing periods:

Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024

Ownership snapshot

Top reported holders of KYMR - Kymera Therapeutics, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

Atlas Venture Life Scienc...

Disclosed value leader

Atlas Venture Life Scienc...

Comparable rows

15/15

Latest evidence

30 Jun 2022

13F Lead comparable stake: 8.3% Showing 1-6 of 15 holder rows.

Quick read

Atlas Venture Life Science Advisors, LLC leads the comparable SEC ownership view at 8.3%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Atlas Venture Life Science Advisors, LLC's linked filing trail.

Comparable ownership Top 5

Atlas Venture Life Science Adviso... 8.3%

PRICE T ROWE ASSOCIATES INC /MD/ 6.3%

WELLINGTON MANAGEMENT GROUP LLP 6.1%

BVF INC/IL 5%

STATE STREET CORP 4.2%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Atlas Venture Life Science Advisors, LLC	13F Company 13F	8.3%	$135,382,000 6,875,698 shares	—	30 Jun 2022
PRICE T ROWE ASSOCIATES INC /MD/	13F Company 13F	6.3%	$102,874,000 5,224,686 shares	—	30 Jun 2022
WELLINGTON MANAGEMENT GROUP LLP	13F Company 13F	6.1%	$99,137,000 5,034,940 shares	—	30 Jun 2022
BVF INC/IL	13F Company 13F	5%	$81,492,000 4,138,758 shares	—	30 Jun 2022
STATE STREET CORP	13F Company 13F	4.2%	$69,199,000 3,514,438 shares	—	30 Jun 2022
BAKER BROS. ADVISORS LP	13F Company 13F	3.5%	$56,704,000 2,879,825 shares	—	30 Jun 2022

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

119

52,859,306

Rows available

119

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2022 vs Q2 2022 Across Filers

Q2 2022 holders

Q3 2022 holders

119

Holder diff

Investor	Q2 2022 Shares	Q3 2022 Shares	Share Diff	Share Chg %	Q2 2022 value	Q3 2022 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend